• Home
  • About APS
  • APS News
  • Job Postings and Ads
  • Events and Education
  • Goverment Affairs
  • 2024 Annual Meeting
  • Education-OUD
  • Education-On Demand
  • Mental Health Resources

To Buy Prevacid Online Visit Our Pharmacy ↓

Click HERE To Buy Prevacid Online ↓




  • Prevacid Vs. Other Ppis: What Makes It Unique?

    Prevacid's Active Ingredient: Unique Characteristics


    Lansoprazole, the active ingredient in Prevacid, stands out in the landscape of proton pump inhibitors (PPIs) due to its unique characteristics. It works by irreversibly blocking the H+/K+ ATPase enzyme system in the stomach lining, which dramatically reduces gastric acid production. This specificity in action not only helps in achieving efficacy for acid-related disorders but also contributes to a faster onset of symptom relief compared to some other PPIs. Additionally, lansoprazole is known for its higher selectivity towards the gastric proton pumps, which can translate to targeted therapy with potentially less systemic disruption.

    Characteristic Details
    Active Ingredient Lansoprazole
    Enzyme Target H+/K+ ATPase
    Action Irreversible enzyme blocking



    Pharmacokinetics: Comparing Absorption and Duration



    Prevacid, a well-regarded proton pump inhibitor, distinguishes itself through its unique pharmacokinetic properties. Unlike some other PPIs, Prevacid is formulated as an enteric-coated capsule or tablet, allowing it to bypass the acidic environment of the stomach and dissolve in the more neutral pH of the intestine. This delayed release simplifies absorption, ensuring a more consistent therapeutic effect.

    In terms of duration, Prevacid offers an impressive timeline of activity. Once absorbed, it exhibits a longer half-life compared to several other PPIs, maintaining effective acid suppression over a 24-hour period with just one daily dose. This feature can enhance adherence to treatment regimens, as fewer doses are needed, making it an appealing option for those seeking uncomplicated therapy.

    Prevacid also exhibits a rapid onset of action, a critical factor for patients dealing with frequent heartburn or gastroesophageal reflux disease. With its quick absorption and sustained duration, users may experience faster relief while benefiting from continuous acid reduction throughout the day. This balance of swift effectiveness and lasting action differentiates Prevacid from others, highlighting its unique place in the PPI landscape.



    Side Effects: How Prevacid Stands Out


    While all proton pump inhibitors (PPIs) come with potential side effects, Prevacid often distinguishes itself by typically being better tolerated among many users. Common side effects, such as headaches and gastrointestinal issues, occur with much the same frequency as other PPIs, but Prevacid users sometimes report fewer severe reactions.

    Additionally, long-term users note that Prevacid's side effects can be manageable with appropriate medical guidance, setting it apart for those sensitive to typical PPI adverse effects. This makes Prevacid a favored choice for those who need ongoing management of acid-related conditions.



    Prescription Guidelines and Over-the-counter Availability



    Prevacid, known for its effectiveness, sets itself apart in the proton pump inhibitor (PPI) landscape partly through its flexible availability. While many PPIs require a prescription, Prevacid offers the added advantage of over-the-counter forms, making it accessible for those experiencing occasional heartburn. This dual availability extends its utility beyond those with chronic conditions, providing options tailored to varying treatment needs. Healthcare providers often consider this flexibility when prescribing Prevacid, balancing initial intervention through prescription doses with continued convenience for ongoing management in its OTC form. This ensures treatment continuity and patient adherence.



    Long-term Use: Potential Benefits and Risks


    Prevacid, known for its effectiveness in managing acid-related disorders, offers both potential benefits and risks when used long-term. For many sufferers of chronic acid reflux or GERD, Prevacid can be a dependable ally, providing relief from persistent symptoms and contributing to an enhanced quality of life. However, as with any medication, prolonged use requires careful consideration. One of the major concerns is the potential for reduced absorption of essential nutrients like calcium and magnesium, which can lead to deficiencies if not monitored properly. Additionally, there is a slight increase in susceptibility to certain infections due to reduced stomach acidity. It's essential for patients and healthcare providers to weigh these factors, ensuring that the relief Prevacid offers is balanced with a mindful approach to potential risks.

    Aspect Benefit/Risk
    Symptom Relief Improved quality of life
    Nutrient Absorption Potential deficiencies
    Infection Risk Slightly increased



    Cost Comparison: Value for Money Among Ppis


    When examining the cost-effectiveness of Prevacid compared to other proton pump inhibitors (PPIs), it's important to consider both the medication's price and its therapeutic value. Prevacid is often found to be on par with alternatives like omeprazole or esomeprazole in terms of efficacy, yet its price can vary significantly depending on whether it's a prescription or over-the-counter purchase.

    In terms of insurance coverage, Prevacid may be more favorable due to its availability as a generic, lansoprazole, which can be more affordable. The balance between cost and effectiveness makes Prevacid an attractive option for long-term treatment despite similar therapeutic outcomes with other PPIs.

    Ultimately, the decision often hinges on factors like individual response and doctor recommendation, but savvy consumers will recognize that Prevacid offers a strong combination of value and accessibility. Considering potential cost savings without compromising efficacy, it remains a competitive choice within the PPI class, appealing to both budget-conscious and health-focused users alike.





ARIZONA PSYCHIATRIC SOCIETY 2024-2025 EXECUTIVE Board

President: Nicholas Ahrendt, MD President-Elect: Margaret Balfour, MD, PhDVice President: Brenner Freeman, MDTreasurer: Robert Rymowicz, DOSecretary: Chiranjir "Ravi" Narine, MD Co Resident-Fellow Member Representatives: Nehal Samra, MD Creighton Matthew Mitchell, MD UA-PhoenixGagan Singh, MD UA-Tucson
APA Assembly Representatives: Jason Curry, DO (serves term concluding 2024) Jasleen Chhatwal, MBBS, MD (two-year term concluding 2024)Payam Sadr, MD (one-year term concluding 2024) Past President Gagandeep Singh, MD, DFAPA Stephen "Larry" Mecham, DO The Society thanks these members for their leadership.

Celebrating our members

Chase was born and raised in Phoenix, AZ, and attended ASU for a bachelor’s degree in business then attended KCUMB for medical school in Kansas City. He was excited to return home to AZ when he found out he'd been matched with UACOM – Phoenix for his psychiatry residency.
He was first drawn to the field of psychiatry during his years in medical school as he found the psychiatric subject matter and the patients to be the most engaging and interesting of all his studies. He quickly came to realize that without a healthy mind, one is unable to thoroughly experience life constructive way. He wanted to be the person to help those struggling with mental illness as he found these cases and experiences to be the most rewarding in medicine.
Dr. Crookham said he has been lucky enough to have been matched at a great psychiatric residency program where he gets to learn from great mentors and colleagues every day. He believes his passion for psychiatry along with the relationships he's developed with his colleagues and mentors will carry him to be a lifelong learner and devoted psychiatrist for his future patients.
Meghan is a graduate of Lincoln Memorial University, DeBusk College of Osteopathic Medicine.
She received her Bachelor of Arts from the University of Denver in French and Biology with a concentration in Cognitive Neuroscience.
She is currently a chief resident at UACOM-Tucson in her final year of psychiatry training and will be starting a fellowship in Addiction Medicine at the University of Arizona, Tucson in July.
Her professional interests include physician mental health, adult consult liaison and addiction psychiatry.
In her personal time, she enjoys home design projects, spending time with family, learning about plants, and exploring new places.
Dr. Hintze is currently honeymooning in Japan! Congratulations!!
Danny is originally from Phoenix. Graduated from Brophy, ASU, and UA Tucson Medical School. His background is in economics, philosophy of science, and rational decision-making.
He was drawn to psychiatry because of the conceptual complexity and the profound impact even relatively simple pharmaceutical, medical, and psychotherapeutic interventions can have to empower patients and their families.
As a mentor, he wanted to recognize the many people within the Arizona Medical Community, particularly at UA Tucson, Valleywise, and within organized medicine who have worked to protect and promote medicine as a joyful, compassionate, and healing experience for patients and for all of us who help care for them.

ARIZONA PSYCHIATRIC SOCIETY past presidents

Otto L. Bendheim, M.D. 1960-1961Warren S. Williams, M.D. 1961-1963T. Richard Gregory, M.D. 1963-1964Boris Zemsky, M.D. 1964-1965 Hal J. Breen, M.D. 1965-1966Joseph M. Green, M.D. 1966-1967Irene M. Josselyn, M.D. 1967-1968Hubert R. Estes, M.D. 1968-1969Richard H. Bruner, M.D. 1969-1970Thomas F. Kruchek, M.D. 1970-1971David S. Burgoyne Sr., M.D. 1971-1972Marshall W. Jones, M.D. 1972-1973Harold D. Haeussler, M.D. 1973-1974William B. Haeussler, M.D. 1974-1975Edward S. Gelardin, M.D. 1975-1976Hugo L. Cozzi, M.D. 1976-1977Robert F. Meyer, M.D. 1977-1978James E. Campbell, M.D. 1978-1979Stuart M. Gould, M.D. 1979-1980Elliot M. Heiman, M.D. 1980-1981Stephen V. Shanfield, M.D. 1981-1982Jerry A. Biggs, M.D. 1982-1983Robert C. Shapiro, M.D. 1983-1984Dennis C. Westin, M.D. 1984-1985John H. Jarvis, M.D. 1985-1986James G. Hill, M.D. 1986-1987Robert P. Bevan, M.D. 1987-1988Eugene J. Kinder, M.D. 1988-1989 James M. Campbell, M.D. 1989-1990David S. Burgoyne II, M.D. 1990-1991
Stuart W. Hollingsworth, M.D. 1991-1992Kevin J. Leehey, M.D. 1992-1993Stephen S. Brockway, M.D. 1993-1994Michael H. Stumpf, M.D. 1994-1995Lauro Amezcua-Patino, M.D. 1995-1996David S. Burgoyne II, M.D. 1997-1998Glenn Lippman, M.D. 1998-1999Lisa Jones, M.D. 1999-2000David J. Coons, M.D. 2000-2001James M. Campbell, M.D. 2001-2002Bradley Johnson, M.D. 2002-2003David W. Leicken, M.D. 2003-2004Thomas N. Crumbley, M.D. 2004-2006Jeffrey L. Schwimmer, M.D., M.P.H. 2006-2007Stephen O. Morris, M.D. 2007-2008Jack L. Potts, M.D. 2008-2009Elizabeth A. Kohlhepp, M.D. 2009-2010Michael E. Brennan, M.D. 2010-2011Gretchen Alexander, M.D. 2011-2012Tariq M. Ghafoor, M.D. 2012-2013Joanna K. Kowalik, M.D., M.P.H., 2013-2014Payam M. Sadr, M.D., 2014-2015Roland Segal, M.D., 2015-2016Gurjot Marwah, M.D., 2016-2017Aaron Wilson, M.D., 2017-2018Mona Amini, M.D., 2018-2019 Don J. Fowls, M.D., 2019-2020 Jasleen Chhatwal, M.B.B.S., M.D., 2020-2022 Stephen Larry Mecham, DO, 2022-2023 Gagandeep Singh, MD, DFAPA 2023-2024
Main Menu
  • Home
  • About APS
  • APS News
  • Job Postings and Ads
  • Events and Education
  • 2023 Annual Meeting
  • Education-OUD
  • Education-On Demand
  • Mental Health Resources
Contact Information
Address: 2401 West Peoria Avenue, Suite 315 Phoenix, Arizona 85029
Phone: 602-909-4388
E-mail: admin@azpsych.org
Social
The Arizona Psychiatric Society is committed to ensuring the accessibility of its website to people with disabilities. If you have trouble accessing any of the Arizona Psychiatric Society's resources, please contact us at admin@azpsych.org for assistance Copyright © 2020 Network Solutions, LLC, A Web.com Company. All rights reserved.

We use cookies to enable essential functionality on our website, and analyze website traffic. By clicking Accept you consent to our use of cookies. Read about how we use cookies.

Your Cookie Settings

We use cookies to enable essential functionality on our website, and analyze website traffic. Read about how we use cookies.

Cookie Categories
Essential

These cookies are strictly necessary to provide you with services available through our websites. You cannot refuse these cookies without impacting how our websites function. You can block or delete them by changing your browser settings, as described under the heading "Managing cookies" in the Privacy and Cookies Policy.

Analytics

These cookies collect information that is used in aggregate form to help us understand how our websites are being used or how effective our marketing campaigns are.